Adrian Gottschalk
2022
In 2022, Adrian Gottschalk earned a total compensation of $5.4M as President and Chief Executive Officer at Foghorn Therapeutics, a 26% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $215,625 |
|---|---|
| Option Awards | $4,645,819 |
| Salary | $575,000 |
| Total | $5,436,444 |
Gottschalk received $4.6M in option awards, accounting for 85% of the total pay in 2022.
Gottschalk also received $215.6K in non-equity incentive plan and $575K in salary.
Rankings
In 2022, Adrian Gottschalk's compensation ranked 572nd out of 5,694 executives tracked by ExecPay. In other words, Gottschalk earned more than 90.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 572 out of 5,694 | 90th |
Division Manufacturing | 242 out of 3,099 | 92nd |
Major group Chemicals And Allied Products | 75 out of 1,406 | 95th |
Industry group Drugs | 63 out of 1,307 | 95th |
Industry Pharmaceutical Preparations | 45 out of 953 | 95th |
Source: SEC filing on May 3, 2024.
Gottschalk's colleagues
We found one more compensation record of an executive who worked with Adrian Gottschalk at Foghorn Therapeutics in 2022.
2022
Steven Bellon
Foghorn Therapeutics